Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1158/0008-5472.CAN-14-2043 http://scihub22266oqcxt.onion/10.1158/0008-5472.CAN-14-2043 C4252249!4252249!25304264     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Res 2014 ; 74 (23): 7069-78 Nephropedia Template TP {{tp|p=25304264|t=2014. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor |pdf=|usr=}}{{25304264}} gab.com Text Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor JO: Cancer Res http://www.kidney.de/pget.php?&tw=1&pmid=25304264 #FOAvip Oxidative stress suppresses host immunity by generating oxidized lipid agonists of the platelet-activating factor receptor (PAF-R). Because many classical chemotherapeutic drugs induce reactive oxygen species (ROS), we investigated whether these drugs might subvert host immunity by activating PAF-R. Here we show that PAF-R agonists are produced in melanoma cells by chemotherapy that is administered in vitro, in vivo or in human subjects. Structural characterization of the PAF-R agonists induced revealed multiple oxidized glycerophosphocholines that are generated non-enzymatically. In a murine model of melanoma, chemotherapeutic administration could augment tumor growth by a PAF-R-dependent process that could be blocked by treatment with antioxidants or cyclooxygenase-2 inhibitors or by depletion of regulatory T cells. Our findings reveal how PAF-R agonists induced by chemotherapy treatment can promote treatment failure. Further, they offer new insights into how to improve the efficacy of chemotherapy by blocking its heretofore unknown impact on PAF-R activation. Twit Text FOAVip Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor ????Cancer Res http://www.kidney.de/pget.php?&tw=1&pmid=25304264 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25304264 #FOAvip English Wikipedia <ref>{{Cite pmid|25304264}}</ref> Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor #MMPMID25304264 Sahu RP; Ocana JA; Harrison KA; Ferracini M; Touloukian CE; Al-Hassani M; Sun L; Loesch M; Murphy RC; Althouse SK; Perkins SM; Speicher PJ; Tyler DS; Konger RL; Travers JB Cancer Res 2014[Dec]; 74 (23): 7069-78 PMID25304264show ga Oxidative stress suppresses host immunity by generating oxidized lipid agonists of the platelet-activating factor receptor (PAF-R). Because many classical chemotherapeutic drugs induce reactive oxygen species (ROS), we investigated whether these drugs might subvert host immunity by activating PAF-R. Here we show that PAF-R agonists are produced in melanoma cells by chemotherapy that is administered in vitro, in vivo or in human subjects. Structural characterization of the PAF-R agonists induced revealed multiple oxidized glycerophosphocholines that are generated non-enzymatically. In a murine model of melanoma, chemotherapeutic administration could augment tumor growth by a PAF-R-dependent process that could be blocked by treatment with antioxidants or cyclooxygenase-2 inhibitors or by depletion of regulatory T cells. Our findings reveal how PAF-R agonists induced by chemotherapy treatment can promote treatment failure. Further, they offer new insights into how to improve the efficacy of chemotherapy by blocking its heretofore unknown impact on PAF-R activation. äChemotherapeutic agents subvert tumor immunity by generating agonists (epmc).pdf DeepDyve Pubget Overpricing